logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Infinity Discovery, Inc.


USPTO Granted Patents = 12

% Expired Patents = 83.3



Trademarks = 3

Forward Citations = 222

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Alfredo C Castro (11 out of 114 patents)

silverMedal Michael J Grogan (9 out of 44 patents)

bronzeMedal Martin R Tremblay (8 out of 47 patents)

4.  Edward Holson (4 out of 44 patents)

5.  Marta Nevalainen (4 out of 17 patents)

6.  Andre Lescarbeau (3 out of 32 patents)

7.  Brian T Hopkins (3 out of 36 patents)

8.  Daniel A Snyder (3 out of 34 patents)

9.  Stephane Peluso (3 out of 26 patents)

10.  James R Porter (3 out of 24 patents)

11.  Nii O Koney (3 out of 8 patents)

12.  Gregg F Keaney (2 out of 21 patents)

13.  Lawrence Blas Perez (2 out of 23 patents)

14.  Tao Liu (2 out of 38 patents)

15.  Thomas T Tibbitts (2 out of 22 patents)


12 patents:

1. 8609706 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners (2013-12-17),
2. 8431566 - Cyclopamine lactam analogs and methods of use thereof (2013-04-30),
3. 8426436 - Heterocyclic cyclopamine analogs and methods of use thereof (2013-04-23),
4. 8357676 - Ansamycin formulations and methods of use thereof (2013-01-22),
5. 8304428 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners (2012-11-06),
6. 8293760 - Cyclopamine lactam analogs and methods of use thereof (2012-10-23),
7. 7994191 - Heterocyclic cyclopamine analogs and methods of use thereof (2011-08-09),
8. 7964590 - Cyclopamine lactam analogs and methods of use thereof (2011-06-21),
9. 7928244 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners (2011-04-19),
10. 7875628 - Cyclopamine analogues and methods of use thereof (2011-01-25),
11. 7648994 - Heterocyclic cyclopamine analogs and methods of use thereof (2010-01-19),
12. 7230004 - Cyclopamine analogues and methods of use thereof (2007-06-12),
Company Overview
Infinity Discovery, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative solutions for drug discovery and development. The organization focuses on harnessing advanced technologies to enhance the efficiency and effectiveness of therapeutic research, particularly in the fields of genomics and proteomics. By leveraging cutting-edge methodologies, Infinity Discovery aims to accelerate the translation of scientific discoveries into viable therapeutic options, contributing to advancements in healthcare and medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

12 Patents

#205 in Cambridge, MA

#1,549 in Massachusetts

#25,578 in US

#48,209 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Infinity Discovery, Inc.

Forward Citations = 222

27 inventors:

goldMedal Alfredo C Castro (11 out of 114 patents)

silverMedal Michael J Grogan (9 out of 44 patents)

bronzeMedal Martin R Tremblay (8 out of 47 patents)

4.  Edward Holson (4 out of 44 patents)

5.  Marta Nevalainen (4 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Infinity Discovery, Inc.. Retrieved from https://idiyas.com/company/infinity-discovery

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…